Bio-Optronics, a workflow solutions company, announced the launch of Clinical Conductor, a new Clinical Trial Management System for practitioners of clinical research. Clinical Conductor is a web-based clinical trial management system for physician’s offices, research centers and academic medical centers.
New generation information technology professionals are restless, get easily bored and want to go up the ladder quickly without becoming experts, says a senior official of Infosys and human resources management specialist.
According to the National Eye Institute, Americans are facing increasing rates of visual impairment from age-related diseases. The articles in this special issue on vision address three general areas: screening for diabetic retinopathy, basic research on treating and preventing vision loss, and management of patients with low vision.
Many patients in the USA with asthma or chronic obstructive pulmonary disease (COPD) do not receive the recommended levels of care, researchers have found.
Researchers report that patients with asthma can achieve near-normal quality of life if they aim for total control of their symptoms.
Dr. Angela Clark, associate professor of nursing at The University of Texas at Austin, is conducting a new study to help people living with chronic heart failure, an illness which affects five million people in the United States. Clark says an estimated one-third to one-half of hospital re-admissions for chronic heart failure could be prevented with better education about symptoms, medications and diet.
JHUSON Associate Professor Miyong T. Kim, PhD, RN and colleagues have found there is a steeply increasing incidence of coronary heart disease (CHD) in developing countries undergoing rapid westernization, including South Korea.
Nutrition 21, Inc., today announced the results of a recent placebo controlled, double-blind, randomized, single center study that demonstrated that Diachrome, a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
Dogs are usually indulged in eating biscuits, and it causes obesity in them. Now dogs have slimming drug Slentrol, manufactured by Pfizer, to control obesity. The Food and Drug Administration (FDA) today is announcing the approval of Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs.
The test results received today from the student at Hopkins Hill Elementary School in Coventry who contracted meningitis showed no connection to the illnesses in Warwick and West Warwick.